Assembly Health Committee advances bills on HIV prevention, clinician-dispensed drugs, wildfire air devices and benchmark benefits; naloxone contracting measure

The Assembly Health Committee met April 29 in Sacramento and considered a broad slate of health legislation, moving several measures to the Appropriations Committee for further review and debate while rejecting at least one high-profile measure tied to state naloxone contracting.

In front of a packed hearing room, members debated bills that ranged from expanding access to injectable HIV pre-exposure prophylaxis (PrEP), to rules that affect how physicians can dispense medications in-office, to targeted disaster-response benefits such as coverage for portable HEPA air purifiers and additional behavioral health visits after wildfires. Lawmakers and witnesses repeatedly framed the discussion around access to care, equity for affected communities, and fiscal and operational impacts on hospitals and health plans.

The most-discussed measures included: - AB 554 (Gonzales), the PREPARE Act: sponsors said the bill clarifies and strengthens state protections that prevent prior authorization and step therapy for PrEP, extend no-cost coverage requirements to more plans and improve reimbursement for injectable PrEP so small community clinics can offer it. Supporters included Equality California and the California Department of Insurance; opposition from insurers raised concerns about potential premium impacts and the state's current affordability targets. Committee members advanced the bill to appropriations.

- AB 577 (Wilson): aimed at preserving physicians' ability to administer and dispense medications in-office when medically necessary. The author accepted committee amendments that narrow the bill to in-network providers, require patient consent and cost transparency, and exempt hospital outpatient settings. Physician groups and oncology and rheumatology associations strongly supported the changes; insurers and pharmacy-benefit managers opposed, citing drug-cost and patient-safety concerns. The committee advanced the bill to appropriations as amended.

- AB 546 (Bauer-Kahan) ' "Clean Air for All": would require health plans to provide coverage for effective portable HEPA purifiers for specified vulnerable beneficiaries during declared wildfire emergencies. Supporters cited CalHHS and multiple public-health studies tying wildfire smoke exposure to respiratory and pregnancy risks; insurers and plans opposed or sought amendments, arguing the bill could set coverage precedent beyond existing essential health benefits processes. The committee advanced the bill to appropriations with the author accepting amendments.

- AB 224 (Bonta) ' Essential Health Benefits benchmark update: the committee advanced a proposal that would codify California's proposed 2027 benchmark additions (infertility services including in vitro fertilization, hearing aids, and expanded durable medical equipment including mobility devices). The Department of Managed Health Care testified that the state has completed the actuarial and public-review process and will submit the package to CMS by the federal deadline.

- AB 1032 (Harabedian) and AB 546 (Harabedian'separate bills on wildfire recovery): measures to expand behavioral-health visits and related disaster supports following declared wildfires were debated; supporters said the bills fill gaps that emerge when local systems are overwhelmed and survivors need rapid, trauma-informed care. Insurers urged caution, noting existing parity and emergency-notification rules and warning against setting uneven disaster-specific coverage rules.

- AB 1113 (Gonzales) ' community clinic mission-spend transparency: one of the most contested items. The bill would require federally qualified health centers (FQHCs) to direct a minimum percentage of revenue (the draft proposed 90%) toward mission-directed patient care and workforce support, with an on-ramp exemption process for financial hardship. Supporters, including clinic workers and union representatives, said public dollars should be clearly tied to patient care and frontline staffing; many clinics and statewide primary-care associations said the proposal as drafted would impose an inflexible, blunt standard that could harm small or rural clinics and divert resources to compliance. The author said she would work with stakeholders and the department to refine definitions, reporting tools, and hardship protections; the committee advanced the bill to appropriations as amended.

- AB 1103 (Ward) ' Research Advisory Panel modernization for federally controlled-substance trials: the bill would create an expedited pathway so California does not delay federally-authorized clinical trials involving schedule I and II substances (including physician-led studies of psychedelics for PTSD and other indications). Supporters included researchers and veteran advocates seeking faster access to trials; the committee advanced the bill.

- AB 1320 (Patterson) ' limiting no-bid contracts for opioid-antagonist supply: the author proposed a prohibition on awarding noncompetitive no-bid contracts for naloxone and other antagonists to manufacturers that had entered opioid-related settlements with states. The bill's intent drew support from bereaved family members and lawmakers who argued the state should not award exclusive, long-term contracts to companies that had allegedly contributed to the opioid crisis. Hospital, pharmacy and generic-drug trade groups warned that restricting suppliers could reduce naloxone availability or raise costs; public-health and harm-reduction advocates were also concerned it could disrupt distribution at the scale California needs. The committee debated the policy and ultimately the measure failed on the floor vote that followed the hearing; the author signaled willingness to negotiate a competitive-bidding approach that avoids disruptions to naloxone supply.

Votes at a glance (committee action; moved to Appropriations unless noted): - AB 554 (Gonzales) ' HIV prevention/PrEP access: moved to Appropriations as amended. - AB 577 (Wilson) ' physician dispensing and in-office medication administration: moved to Appropriations as amended. - AB 546 (Bauer-Kahan) ' HEPA purifiers for vulnerable enrollees during declared wildfire emergencies: moved to Appropriations as amended. - AB 224 (Bonta) ' essential health benefits benchmark additions: moved to Appropriations as amended. - AB 1032 (Harabedian) ' additional behavioral-health visits after wildfire emergencies: moved to Appropriations as amended. - AB 1113 (Gonzales) ' mission-spend ratio for community clinics: moved to Appropriations as amended (contentious; many stakeholders pledged ongoing negotiations). - AB 1103 (Ward) ' expedited review for controlled-substance research (RAPC): moved to Appropriations as amended. - AB 1320 (Patterson) ' limits on awarding no-bid naloxone contracts to companies that participated in opioid settlements: failed in committee vote (sponsors signaled willingness to refine approach).

Why it matters - Access and equity: Members repeatedly returned to the theme that coverage mandates, program design, and administrative rules have immediate downstream effects on the ability of clinics, community organizations and patients to get care. Measures in this hearing try to balance patient access (PrEP, HEPA devices, naloxone) with cost, insurer compliance and administrative feasibility. - System resilience: Several bills responded to shocks ' wildfires, the fentanyl and opioid crisis, and gaps in behavioral-health capacity ' and focused on short-term emergency responses and longer-term infrastructure. - Trade-offs and implementation: Multiple bills passed to appropriations subject to fiscal review. Committee members and agency witnesses emphasized the need for precise definitions, workable reporting mechanisms and hardship off-ramps to avoid unintended consequences (for clinics, hospitals and safety-net services).

What comes next Bills sent to the Assembly Appropriations Committee will be reviewed for fiscal impacts and may be amended again before floor votes. Several authors pledged continued talks with hospital associations, insurers, county health departments and provider unions to narrow language and resolve implementation questions. The most contentious measures ' notably the community-clinic mission-spend proposal and the naloxone contracting proposal ' are likely to see additional negotiations.

That meeting also included routine consent-calendar business and procedural votes that the committee handled before adjourning.

Ending The committee's action left several major policy questions unresolved: how to guarantee access while controlling costs, how to harmonize disaster-response benefits with existing benefit design and parity laws, and how to ensure public dollars and contracts promote both availability and corporate accountability. Lawmakers and stakeholders signaled intention to continue negotiating those trade-offs as bills move into fiscal review.

(Reporting based on live hearing transcript and on-the-record committee presentations.)